Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Acura must provide FDA more info on pain drug

Regulator questions abuse-resistant ability of Aversion

- PMLiVE

The death of traditional consumerism

What does it mean for pharma and how can empowering patients open up new possibilities to the industry

- PMLiVE

NICE backs Gilead’s Sovaldi in hepatitis C

But health watchdog denies earlier use of Janssen’s Zytiga

- PMLiVE

US panel backs pneumococcal vaccines for seniors

Vaccines to be provided by Merck & Co and Pfizer

- PMLiVE

Avastin gets US green light for late-stage cervical cancer

Fifth oncology indication for Roche’s medicine

- PMLiVE

Cancer Research UK calls for accuracy on Wikipedia

Appeals to healthcare community to keep online information up to date

- PMLiVE

GE Healthcare makes changes in Asia

Olivier Loeillot appointed general manager, Asia commercial for BioProcess division

- PMLiVE

Rebif hit again as competition bites

Merck Serono’s MS drug continues its struggle for sales in the US and Europe

- PMLiVE

Celltrion submits biosimilar Remicade for US approval

Drug is second to be assessed by FDA under biosimilars pathway

- PMLiVE

AZ takes asthma antibody into phase III

Tralokinumab tipped as potential blockbuster

- PMLiVE

FDA approves Merck’s insomnia drug

Belsomra is first orexin receptor antagonist available in US

- PMLiVE

Sanofi ships synthetic malaria jab

French manufacturer says Gates Foundation-funded venture could widen treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links